Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chapter 8: Screening for cervical cancer in developing countries.

Lynette Denny1, Michael Quinn, R Sankaranarayanan

  • 1Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. ldenny@uctgsh1.uct.ac.za

Vaccine
|September 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.

Pediatrics·2026
Same author

Plasma Cytokine and Chemokine Profile in Hospitalized Toxic Epidermal Necrolysis Patients.

Clinical and experimental dermatology·2026
Same author

Universal Newborn Screening for Congenital Cytomegalovirus Using Dried Blood Spot Specimens.

JAMA network open·2026
Same author

The International Gynecologic Cancer Society Global Fellowship Program: advancing access to gynecologic oncology and surgical care worldwide.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Engaging with Film to Teach Students About Virtuous Outsourcing of Cognitive Tasks to LLMs.

Digital society : ethics, socio-legal and governance of digital technology·2025
Same author

Large Language Models' Clinical Decision-Making on When to Perform a Kidney Biopsy: Comparative Study.

Journal of medical Internet research·2025
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Cervical cancer screening programs using cytology have reduced cancer rates, but new, accessible methods are needed, especially in developing nations. Alternative approaches show promise, with integrated screening and treatment strategies being safe and effective.

Area of Science:

  • Oncology
  • Public Health
  • Gynecology

Background:

  • Cytology-based cervical cancer screening programs have significantly decreased cancer incidence in developed nations.
  • Significant barriers hinder the implementation of cytology screening, particularly in developing countries.
  • This necessitates the exploration of novel and alternative cervical cancer prevention strategies.

Purpose of the Study:

  • To review alternative approaches to cervical cancer screening beyond traditional cytology.
  • To evaluate the feasibility and effectiveness of integrated screening and treatment strategies.
  • To identify country-specific solutions for establishing effective cervical cancer screening programs.

Main Methods:

  • Review of existing literature on cervical cancer screening methods.

Related Experiment Videos

  • Analysis of the performance of alternative screening approaches compared to cytology.
  • Examination of the safety, feasibility, and effectiveness of one- or two-visit screening and treatment strategies.

    • Main Results:

    • Alternative screening approaches demonstrate comparable or superior performance to cytology, though often with lower specificity and higher false-positive rates.
    • Linking screening with treatment in a one- or two-visit model is safe, feasible, and effective.
    • Barriers and challenges in establishing screening programs vary significantly by country.

    Conclusions:

    • Novel screening methods offer viable alternatives to cytology for cervical cancer prevention, especially where cytology programs face implementation challenges.
    • Integrated screening and treatment strategies represent a promising approach for improving cervical cancer control.
    • Tailored, country-specific solutions are essential for successful cervical cancer screening program implementation, considering successful program criteria.